Articles tagged with Scientific Workforce
A new editorial provides guidance on writing constructive peer reviews, emphasizing key takeaways such as 'picking battles' and maintaining professional courtesy. The guidance aims to elevate scientific data quality while mitigating impacts on authors' reputation and mental wellbeing.
The summit brought together endocrine leaders to identify opportunities to work closely together on increasing the visibility of endocrine health in policy decisions. Early findings from a workforce survey revealed challenges including long patient waiting times and retention concerns among early-career clinicians.
The study found that researchers value the university's commitment to diversity and anti-discrimination measures and are broadly satisfied with their working conditions. However, respondents identified areas for improvement, including the need for structured institutional support and clear procedures to prevent discrimination. The find...
The Cure Innovation Index ranks top US biomedical institutions based on their ability to translate scientific discoveries into real-world healthcare solutions. The index identifies key factors such as commercialization infrastructure, industry engagement, and entrepreneurial culture that enable translational success.
A nationally representative survey found that nearly 7 in 10 people trust vaccine scientists to act in their best interests, similar to medical scientists and scientists in general. The public perceives vaccine scientists as credible, self-correcting, and unbiased, with their work benefiting society.
Binghamton University's new initiative aims to advance artificial intelligence for the public good by educating students on foundational AI principles, workforce applications, and ethical considerations. The three-year, $900,000 program includes a free online microcredential and student research opportunities.
Lindsay Squeglia, Ph.D. of the Medical University of South Carolina received the 2026 ACTS Award for Supporting an Excellent Translational Science Workforce. She is a leading figure in substance use prevention and adolescent brain development research.
The Alliance for Clinical Trials in Oncology has several active trials specifically designed to help people with head and neck cancers. Trials include testing high-dose prophylactic gabapentin to prevent opioid use during treatment, as well as immunotherapy with nivolumab and cabozantinib for mucosal melanoma and nasopharyngeal carcino...
Dr. Gobbi challenges the global drug-development system, stating that promising treatments for mental illness are failing to reach patients due to venture capital and profit motives. Her research focuses on cannabis, melatonin, and psychedelics, with a goal of improving public-health decisions and treatment outcomes.
Dr. Phillips's laboratory identifies abnormalities in prefrontal-striatal-limbic circuitry as biomarkers for bipolar disorder before symptoms appear. Her team tracks neural network development from infancy through young adulthood.
Dr. Cazares co-founded Colors of the Brain and advocated for GRE removal to support students from underprivileged backgrounds. He aims to bring neuroscience to underserved communities through portable, affordable, and non-invasive methods.
Xiwen Gong and Zhen Xu, both from the University of Michigan Engineering, received the award for developing optoelectronics and histotripsy, a cancer treatment using sound waves. The new treatment can spare patients from chemotherapy and radiation therapy.
An international working group has been appointed to advance the Global Workforce Development in Stem Cell Research and Regenerative Medicine Initiative, a collaboration between ISSCR and Canada's Stem Cell Network. The initiative aims to strengthen workforce development and ensure the field of regenerative medicine delivers meaningful...
The University of Bath has achieved a record number of finalist status in this year's everywoman in Technology Awards 2026. Academics from various departments have been recognized for their leadership, innovation and commitment to advancing women in technology.
The Society for Laboratory Automation and Screening (SLAS) has developed a comprehensive framework to educate scientists on laboratory automation, addressing the growing gap between technology adoption and training pathways. The project aims to create shared standards for automation education, expanding access to training across instit...
The Giant Magellan Telescope has appointed Daniel T. Jaffe as its new president, succeeding Robert Shelton, who announced his retirement last year. Jaffe brings decades of leadership experience in research, astronomy instrumentation, and academia to lead the observatory through its next phase of construction.
Dr. Jennifer Rood, Associate Executive Director for Cores and Resources, takes on interim leadership role at Pennington Biomedical Research Center while an international search for the next full-time Executive Director is underway. She brings over 30 years of experience in obesity and chronic disease research.
Dr. Noritaka Ichinohe challenges the long-held assumption that averaging away individual differences is necessary in psychiatric research. Instead, biological heterogeneity is seen as a phenomenon demanding explanation. The author's work on primate brain mapping and molecular subtyping has identified convergence points between species ...
Dr. Maria Margarita Behrens' work deciphers the molecular signatures defining every human brain cell type, shedding light on neural development and psychiatric disorders. Her single-cell epigenomic atlases will enable researchers to target specific cell types with unprecedented precision.
Professor Dan Stein was a visionary who bridged neuroscience, clinical care, and philosophy to transform psychiatric research in Africa. His integrative approach produced scholarship of extraordinary range, with over 1,600 peer-reviewed publications and a Google Scholar h-index exceeding 220.
Dr. Eric J. Nestler's research has fundamentally reshaped global understanding of addiction and depression by focusing on resilience rather than pathology. His laboratory identified distinct molecular, cellular, and circuit changes in resilient brains that maintain normal behavioral function despite exposure to drugs or stress.
A11yShape, an AI-assisted tool, enables visually impaired computer programmers to create, edit and verify complex 3D models without assistance. The tool uses GPT-4o to provide detailed descriptions of the model for blind and low-vision programmers.
Dr. Paul Lucassen's research on adult neurogenesis reveals the link between early life experiences, lifestyle factors, and depression/dementia risk. His work has implications for therapeutic approaches to brain health and disease.
Dr. Corby Martin has been appointed as the Associate Executive Director for Scientific Education at Pennington Biomedical Research Center. He will provide leadership for key programs such as the T32 Postdoctoral Training Program, the Pennington Scientific Symposium and the Bray Obesity Symposium.
Research universities see no correlation between non-academic staff and efficiency, but teaching-oriented universities experience a positive correlation. Administrative staff play a key role in improving performance in these institutions.
The ISSCR and SCN are partnering to develop a global conversation on workforce development in regenerative medicine, examining current challenges and identifying skills gaps. The joint initiative aims to build the talent required for continued discovery and innovation in the field.
The Damon Runyon Cancer Research Foundation has named the newest cohort of SPARK Scholars, providing post-baccalaureate scholars with research training, mentors, and networking opportunities. The program's recipients will conduct cancer research in top institutions and present their findings at the annual Damon Runyon Fellows' Retreat.
Anna Krylov, a professor of chemistry at the University of Southern California, receives the award for her pioneering contributions to theoretical and computational chemistry. Mikhail Yampolsky, a cultural scholar and historian, wins the award for his unique original contributions in cultural theory. The award aims to promote Russian s...
Groundbreaking research by Dr. Bruce M. Cohen has uncovered critical abnormalities in energy metabolism and cellular connectivity that contribute to psychiatric disorders. The study's findings suggest therapeutic avenues that may be better targeted and more effective than current treatments.
A renowned geneticist, Dr. Martin Alda, has made a groundbreaking discovery that bipolar disorder is composed of multiple genetically distinct disorders, transforming treatment approaches worldwide. His research also highlights the importance of combining basic research with clinical observations to advance psychiatric care.
The OIST/NAIST initiative aims to promote the recruitment, development, and retention of foreign doctoral talent in Japan. Foreign PhD holders with advanced expertise and international experience are expected to support Japan's future success.
David Stern, a Senior Group Leader at Janelia Research Campus, joins Stowers Institute to uncover new avenues of biology with enormous implications. His lab discovered 'bicycle proteins' that trick plants into growing protective homes for aphids, shedding light on the battle between plants and insects.
Dr. Alex Tsompanidis proposes placental hormone production shaped human cognitive capabilities, redefining autism origins and neurodiversity. His research could lead to screening protocols and support for children with developmental differences.
A new analysis reveals African women remain significantly underrepresented in water governance, with only 17% of national ministries led by women. Practical steps are needed to address social and institutional barriers and ensure women's equal representation in shaping policies and decisions.
Dr. Gerhard Andersson's pioneering work in internet-delivered cognitive behavioral therapy has produced over 200 controlled trials and transformed mental healthcare accessibility across continents.
Dr Oliver Pain develops GenoPred platform advancing personalized mental healthcare worldwide through accessible genetic tools, democratizing access to cutting-edge genomic methodologies. His work aims to reduce global health inequities by developing inclusive polygenic scoring methods that perform accurately across all ancestry groups.
A study by Dr. Esther Sternberg highlights the importance of social engagement, intellectual stimulation, purposeful activity, humor, and spiritual exploration in achieving exceptional cognitive and social functioning in advanced age. Dr. Reichlin's example challenges conventional assumptions about aging trajectories.
Professor Siegfried Kasper reveals biological bases of psychiatric disorders alongside psychosocial determinants, influencing treatment protocols globally. His pioneering research transformed approaches to treatment-resistant depression, improving millions of lives.
Professor Gregor Hasler's pioneering research reveals how psychedelics like LSD, psilocybin, and MDMA enhance neuroplasticity, allowing the brain to rewire itself and break free from depression, PTSD, and addiction. His discoveries have the potential to fundamentally alter international approaches to mental health treatment.
Dr. Harriet de Wit's groundbreaking research bridges animal and human drug studies, demonstrating that MDMA enhances feelings of social connectedness and challenging addiction treatment strategies. Her discoveries have profound implications for treating trauma-related disorders globally.
Dr. Rentería's Australian Parkinson's Genetics Study (APGS) includes nearly 20,000 volunteers, generating a comprehensive genetic database to understand Parkinson's disease variability. He incorporates wearable sensors and digital biomarkers to address clinical heterogeneity.
Research reveals neuroglia play active role in brain function, driving disease progression through atrophy and functional decline. Therapeutic strategies targeting neuroglial signaling may prevent damage following brain injury or protect against neurodegenerative processes.
Dr. David Rubinsztein shares his personal journey from childhood curiosity to discovering autophagy, a natural process that clears toxic proteins causing devastating neurodegenerative diseases. His research has established autophagy upregulation as a viable therapeutic strategy for conditions affecting millions worldwide.
Binghamton University faculty have received over $4.4 million in National Science Foundation CAREER Awards to pursue innovative research in various fields. The awards recognize academics who have the potential to serve as role models and leaders in research and education.
Leading trauma researcher Professor Philip Hyland's work on Complex PTSD fundamentally changed World Health Organization diagnostic criteria, impacting how clinicians worldwide assess and treat trauma survivors. His innovative measurement tools, such as the International Trauma Questionnaire, challenge decades of clinical tradition and...
The Living Brain Project at Mount Sinai has collected over 300 brain tissue samples, revealing that 80% of genes exhibit different expression levels in living versus postmortem brain tissue. This challenges decades of neuroscience research based on postmortem samples.
Dr. David Rubinow's research reveals that susceptible women respond differently to normal hormonal fluctuations, leading to breakthrough treatment approaches and FDA-approved medication for postpartum depression. His work validates the experiences of millions of women whose hormone-related mood symptoms were previously misunderstood.
Dr. Camilo de la Fuente-Sandoval has developed a groundbreaking approach to schizophrenia treatment prediction using neuroimaging and comprehensive clinical care. His team's research reveals elevated glutamate levels in the associative striatum that normalize with effective antipsychotic treatment.
The AADOCR Mind the Future Program will fund year six of its mentoring network program, supporting up to ten early-career investigators in dental, oral, and craniofacial research. The program aims to develop a sustainable national mentoring network enhancing career development for future researchers.
Aging and depression are linked to complex brain-body communication, with organs aging at different rates and influencing disease susceptibility. Dr. Hamilton Oh's research reveals how immune cells and metabolic organs amplify or dampen mood symptoms, offering novel therapeutic targets.
The Damon Runyon Cancer Research Foundation has awarded $4.2 million to five new Clinical Investigators conducting patient-oriented cancer research. The awards will support the development of new treatments for cancer patients, with a focus on enhancing efficacy and safety.
Dr. Randy J. Nelson's research reveals that artificial light exposure disrupts immune function, causes neuroinflammation, and influences mood regulation. His work has significant implications for understanding depression and anxiety disorders, as well as the obesity epidemic.
Gene coexpression analysis reveals optimal markers of cell types and states, providing opportunities for developing novel biomarkers and targeted treatment strategies for glioma patients. Dr. Oldham's work tackles the reproducibility crisis in science, emphasizing data metadata standardization.
Dr. Xuyu Qian's pioneering research using MERFISH technology created an unprecedented developmental atlas of the human cerebral cortex, analyzing over 18 million single cells. His work aims to identify mechanisms disrupted in conditions like malformations and autism spectrum disorder.
A Brazilian researcher is studying induced pluripotent stem cells from centenarians to understand cellular resilience in COVID-19 survivors. The study aims to identify key cellular pathways that influence longevity and potentially contribute to therapeutic approaches for age-related diseases.
Dr. Eric Sun's groundbreaking work uses spatial aging clocks to measure biological age at the individual cell level, identifying specific cell types that drive brain aging in neighboring tissues. His machine learning models reveal complex intercellular communication networks that determine aging rates.
Sara Poletti's research reveals how childhood trauma triggers persistent neuroinflammation pathways and alters brain structure, creating lifelong vulnerability to psychiatric disorders. Her work identifies biological markers of trauma and explores prevention strategies to reduce mental illness odds.
Dr. John Oldham's contributions have fundamentally reshaped personality disorder classification, moving from rigid categories to a more nuanced dimensional system. His Alternative DSM-5 Model for Personality Disorders (AMPD) has marked the most significant epistemological shift in psychiatric diagnosis for decades.
A pioneering research brings psychedelic medicine into gastroenterology, exploring psilocybin's effects on treatment-resistant irritable bowel syndrome (IBS). Dr. Erin E. Mauney's study modulates interoception and uses integrated therapy sessions with neuroimaging to track brain changes.
Professor Benedetti's research explores the intersection of genetics, environmental factors, and treatment response in mood disorders. His work has led to breakthroughs in chronotherapeutics and immuno-psychiatry, revealing crucial insights into immune-inflammatory mechanisms and gene variants influencing brain function.